Ozempic 和 Wegovy 等减肥药可以预防 42 种健康问题，但会增加胃肠道问题和关节炎的风险。 Weight-loss drugs like Ozempic and Wegovy may prevent 42 health issues but raise risks of GI problems and arthritis.

《自然医学》上的一项研究表明，像 Ozempic 和 Wegovy 这样的减肥药可能提供超越肥胖和糖尿病治疗的更广泛的健康益处。 A study in Nature Medicine suggests that weight-loss drugs like Ozempic and Wegovy may offer broader health benefits beyond obesity and diabetes treatment. 根据 240 万参与者的数据，这些药物与 42 种健康状况的较低风险有关，包括中风、痴呆和物质使用障碍。 Based on data from 2.4 million participants, the drugs were linked to a lower risk of 42 health conditions, including stroke, dementia, and substance use disorders. 然而，它们也增加了胃肠道问题和关节炎的风险。 However, they also increased risks of gastrointestinal issues and arthritis. 研究人员警告说，虽然研究结果很有希望，但需要进一步的研究来证实结果并了解对非糖尿病人群的影响。 Researchers caution that while the findings are promising, further studies are needed to confirm the results and understand the effects in non-diabetic populations.